The table below shows Celldex Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Revenue
$22.00K
$15.00K
-
$730.00K
$695.00K
$3.19M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$67.54M
$73.00M
$62.93M
$54.20M
$52.61M
$45.26M
CLDX annual revenue (10-K history)
Celldex Therapeutics, Inc. reported annual revenue of $1.54M for fiscal year 2025. That is down 78.0% from $7.02M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $6.79M (FY 2016) to $1.54M. Figures come from the company's audited annual reports as filed with the SEC.
